Work

Developing Drugs for Cognitive Impairment in Schizophrenia

Year: 2005

Type: review

Source: Schizophrenia Bulletin

DOI: 10.1093/schbul/sbi051

Author: Alan Breier

Institution: Eli Lilly (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2109714571

FWCI: 0.454

Cites: 41

Cited by: 30

Related to: 10